This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Summit At ChinaBio Partnering Forum
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026
Book Now
Menu
Book
Key Sessions
Hideto Yamaguchi
Innovation in the Manufacturing of Cell Therapy Products Pioneered by Robotics and AI
Cellafa Bioscience Inc.
Nicoletta Loggia
Keynote Presentation: The Next Frontier of Gene Therapy: A Strategic Roadmap for Scale and Access
Orchard Therapeutics
keyboard_arrow_right

April 28 - Day 1 - CT (China Time, GMT+08:00)

keyboard_arrow_leftSearch & Filter
search
April 28 - Day 1 - CT (China Time, GMT+08:00)
search
Opening Keynote Session: Technology Evaluation, Collaboration and Investment Opportunities for Cell and Gene Therapies
Showing 1 of 1 Streams
09:00 - 09:45
Keynote Panel Discussion: Big Pharma’s Cell and Gene Therapies Wish List: Investment Priorities and Emerging Opportunities for Chinese Biotechs
  • Which cell and gene therapy modalities, disease areas, and technologies are top priorities for big pharma investment?
  • What are big pharma looking to license in the next 9-12 months?
  • What are the key breakthroughs shaping pharma’s next moves in CGT?
  • What are the priorities for the Chinese community and how can Chinese biotech’s align with big pharma’s R&D needs?
  • Tony (Bizuo) Liu - Chairman and CEO, AbelZeta Pharma, Inc.
  • Yichao Fan - Executive Director, AstraZeneca International BD&AZ-CICC Fund, AstraZeneca
09:45 - 10:30
Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies
  • Snapshot into the investment landscape for cell and gene therapy products and enabling technologies for 2026/ 2027 and beyond
  • Technology evaluation and product development areas – What are investors interested in investing in, for China and globally?
  • Positioning for success in a competitive funding environment: What do investors need to see?
  • Jenny Yang - Head of External Innovation Asia-Pacific, Novo Nordisk
  • Jieyu Zou - Partner, LAV
  • Matthieu Coutet - Partner, Sofinnova Partners
  • Dan Liu - Managing Partner, Pivotal bioVenture Partners China
  • William Sun - Director, China Head of Healthcare, Citi Commercial Bank, Citi
April 27 - Day 0
NextApril 29 - Day 2
Filter
Topics
Clear
Choose Day